Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365.
Journal: Journal of medicinal chemistry
Published: July 10, 2026
Correction to "Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005".
Journal: Journal of medicinal chemistry
Published: December 12, 2024
Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.
Journal: Journal of medicinal chemistry
Published: August 06, 2021
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma.
Journal: Journal of medicinal chemistry
Published: March 05, 2020
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.
Journal: Journal of medicinal chemistry
Published: October 10, 2017
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115.
Journal: Journal of medicinal chemistry
Published: June 24, 2015
Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223.
Journal: Journal of medicinal chemistry
Published: June 18, 2015
Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase.
Journal: Bioorganic & medicinal chemistry letters
Published: November 30, 2012
Mustelid herpesvirus-2, a novel herpes infection in northern sea otters (Enhydra lutris kenyoni).
Journal: Journal of wildlife diseases
Published: January 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026